MEDICAL DEVICE REGULATIONS EVOLVE FOR AUSTRALIAN INNOVATORS WITH EUROPEAN AMBITIONS Notified body and approved body attend Regulatory Summit to support access to the EU market.
With
Gabrielle Cesvet,
Head of Public Affairs, Scarlet
Tirion Evans, Head of Technical Operations &
Head of Notified Body, Scarlet
SEGMENT
Filmed in Sydney | October 2026
Medical device regulation is undergoing significant change as regulators across major jurisdictions grapple with the rapid growth of software and artificial intelligence (AI) in healthcare.
Speaking with Australian Health Journal at the Medical Technology Association of Australia’s RegConnect Summit 2026 in Sydney in September, Gabrielle Cesvet, Head of Public Affairs at Scarlet, said manufacturers need greater clarity and sufficient lead time as new regulatory frameworks emerge.
“We need to make sure that from a regulatory perspective and from a conformity assessment perspective, we’re able to keep pace with that innovation,” she said.
Cesvet highlighted reforms underway in the European Union, including efforts to simplify the Medical Device Regulation (MDR), reduce regulatory burdens and create a framework better suited to software and AI. She also pointed to the UK’s plans to revamp its regulatory system and increase international reliance.
Tirion Evans, Head of Technical Operations and Head of Notified Body at Scarlet, said the company is increasingly working with Australian manufacturers seeking access to international markets. Scarlet operates as a Notified Body in the EU, an Approved Body in the UK and a Third Party Review Organization in the US.
Evans encouraged innovators to address regulatory requirements early rather than waiting until products are fully developed.
“The most important thing is to try and tackle the regulatory issues right at the beginning,” she said.
The interviews highlighted the growing importance of regulatory expertise in helping innovative software and AI medical devices reach markets efficiently while keeping pace with technological change.
- Source: Adapted from transcript using AI
- Media access credit: Medical Technology Association of Australia (MTAA), RegConnect Summit 2026, Sydney September, 2026
-
New clinical research entity first to operate across both Australia and New Zealand
Over the past 30 years, 18,000 clinical trials that have been registered in Australia, with the sector contributing $1.4 billion to Australia’s economy annually. Trials are a critical aspect of evidence-based medicine, and are essential for testing how new treatments, tests and vaccines will work. In New Zealand they contribute $146 million to the New Zealand economy.
To capitalise on this unique position and growth, a coordinated multi-site clinical research operation was missing, until now.
-
Cardiologist broadens Tasmania’s surgical abilities
Dr Heath Adams is a Tasmanian born, bred and educated interventional and structural cardiologist who works at Hobart Private and Royal Hobart Hospital and is a researcher through the Menzies Research Institute.
Dr Adams clinical interest and expertise is in the management of aortic stenosis, valvular heart disease and acute coronary syndromes. Dr Adams performs coronary interventions including stenting, and structural heart interventions including TAVI, mitral edge to edge repair, mitral valve replacement and left atrial appendage closure. In 2020, Heath performed the first TAVI in Tasmania, is the clinical lead for the local program at the Royal Hobart Hospital and is a nationally accredited TAVI practitioner.
-
Interview with Kylie Ward, CEO Australian College of Nursing
Kylie Ward, CEO Australian College of Nursing spoke with Anne Dao from Australian Health Journal, at last week’s Australian Healthcare Week Expo on the vital role of the nursing professional.
Australian College of Nursing oversees 390,000 nurses in Australia and is the national leader in the nursing profession.
Changes in nursing policy are needed in areas of aged care, chronic disease and workforce sustainability. There are forecasts of shortages in nursing by the year 2025 of 80,000 and by 2030 the number growing by 125,000.
Kylie also mentioned the new Nursing Trailbrazers Award that has been recognised by Federal Health Minister, Greg Hunt. The 4 finalists have been recognised for influencing models of care, and implementing game changing initiatives across the country. They will be presented at the Nursing Now Australia event held by the ACN on 9th April.
